MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
5.26
+0.04
+0.77%
Closed 19:45 08/17 EDT
OPEN
5.15
PREV CLOSE
5.22
HIGH
5.34
LOW
5.13
VOLUME
795.41K
TURNOVER
0
52 WEEK HIGH
9.94
52 WEEK LOW
4.270
MARKET CAP
318.03M
P/E (TTM)
-1.1371
1D
5D
1M
3M
1Y
5Y
1D
Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.0%, Outperforms Peers
Dow Jones · 11h ago
Weekly Report: what happened at VNDA last week (0810-0814)?
Weekly Report · 22h ago
Corbus Pharmaceuticals Holdings Inc. Stock Falls 7.0%, Underperforms Peers
Dow Jones · 08/10 20:32
Vanda Pharmaceuticals Price Target Cut to $12.00/Share From $17.00 by B. Riley Securities
Dow Jones · 08/10 17:28
B. Riley Securities Reiterates Buy on Vanda Pharmaceuticals, Lowers Price Target to $12
Benzinga · 08/10 17:17
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Vanda (VNDA) and AbCellera Biologics (ABCL)
TipRanks · 08/10 12:40
Vanda Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 08/10 10:32
Vanda Pharmaceuticals Price Target Cut to $20.00/Share From $21.00 by HC Wainwright & Co.
Dow Jones · 08/10 10:32
More
About VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company, which is focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company's commercial portfolio consist of four products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome, PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS) including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease , and NEREUS for the prevention of vomiting induced by motion. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.